Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05505227 · ClinicalTrials.gov registry record · NA
Developing a Tailored Stigma Reduction Intervention to Increase Buprenorphine Prescribing
A NA study of Opioid-Related Disorders and Buprenorphine, sponsored by Ohio University.
- Active
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT05505227 is a NA study of Opioid-Related Disorders and Buprenorphine that is active but no longer recruiting, run by Ohio University. The registered enrollment target is 400 participants, above the 338-participant average among 47 other Opioid-Related Disorders trials with a reported enrollment target (18% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05505227, a NA study of Opioid-Related Disorders and Buprenorphine, is active but no longer recruiting, sponsored by Ohio University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
Buprenorphine is an evidence-based treatment for opioid use disorder that also has strong potential to reduce HIV transmission in people who use drugs. Rural health care professionals are eligible and critically needed to provide these medications, but stigma currently limits provider willingness to prescribe buprenorphine, especially in regions where mortality and HIV transmission secondary to opioid use are high. In this developmental trial, the investigators will adapt, refine, and test the feasibility of a prototype brief stigma-reduction training intervention aimed at increasing buprenorphine prescribing in the rural primary care setting.
Conditions Studied
Interventions
- BEHAVIORAL Placebo
- BEHAVIORAL Stigma-reduction training
Study Locations (1)
Ohio
- Berkeley Franz - Athens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2025-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05505227
The ClinicalTrials.gov registry entry for NCT05505227 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 338-participant average among 47 other Opioid-Related Disorders trials with a reported enrollment target (18% higher). The listed sponsor is Ohio University, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Opioid-Related Disorders appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05505227 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05505227 about?
NCT05505227 is a clinical study titled "Developing a Tailored Stigma Reduction Intervention to Increase Buprenorphine Prescribing". Buprenorphine is an evidence-based treatment for opioid use disorder that also has strong potential to reduce HIV transmission in people who use drugs. Rural health care professionals are eligible and critically needed to provide these medications, but stigma currently limits provider willingness to...
What is the current status of trial NCT05505227?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2022-09-01. Estimated completion is 2025-06-30.
What conditions does trial NCT05505227 study?
This clinical trial studies the following conditions: Opioid-Related Disorders, Buprenorphine, Social Stigma, Rural Health Services.
What interventions are being tested in trial NCT05505227?
The interventions under investigation include: Placebo (BEHAVIORAL), Stigma-reduction training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05505227?
This trial is sponsored by Ohio University, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05505227 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Developing and Evaluating a Machine-Learning Opioid Overdose Prediction & Risk-Stratification Tool in Primary Care
RECRUITING · NA
-
Developing a Smartphone Application to Support Veteran Opioid Use Disorder Treatment
RECRUITING · NA
-
OUD Smartphone Services
ACTIVE NOT RECRUITING · NA
-
Healthy Opioid Prescription Engagement
ACTIVE NOT RECRUITING · NA
-
Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk
ACTIVE NOT RECRUITING · NA
-
More Individualized Care: Assessment and Recovery Through Engagement
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.